Aeterna Zentaris Performance
| AEZSDelisted Stock | USD 6.14 0.08 1.29% |
The firm shows a Beta (market volatility) of 1.44, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aeterna Zentaris will likely underperform. Aeterna Zentaris right now shows a risk of 0.0%. Please confirm Aeterna Zentaris treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Aeterna Zentaris will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Aeterna Zentaris has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Aeterna Zentaris is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 50.6 M |
Aeterna |
Aeterna Zentaris Relative Risk vs. Return Landscape
If you would invest 614.00 in Aeterna Zentaris on September 30, 2024 and sell it today you would earn a total of 0.00 from holding Aeterna Zentaris or generate 0.0% return on investment over 90 days. Aeterna Zentaris is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Aeterna, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aeterna Zentaris Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aeterna Zentaris' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aeterna Zentaris, and traders can use it to determine the average amount a Aeterna Zentaris' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AEZS |
Based on monthly moving average Aeterna Zentaris is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aeterna Zentaris by adding Aeterna Zentaris to a well-diversified portfolio.
Aeterna Zentaris Fundamentals Growth
Aeterna Stock prices reflect investors' perceptions of the future prospects and financial health of Aeterna Zentaris, and Aeterna Zentaris fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aeterna Stock performance.
| Return On Equity | -0.82 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | 15.15 M | |||
| Shares Outstanding | 3.06 M | |||
| Price To Earning | 15.42 X | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 7.60 X | |||
| Revenue | 4.58 M | |||
| EBITDA | (18.17 M) | |||
| Cash And Equivalents | 58.16 M | |||
| Cash Per Share | 11.98 X | |||
| Total Debt | 277.57 K | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 10.68 X | |||
| Cash Flow From Operations | (17.43 M) | |||
| Earnings Per Share | (2.30) X | |||
| Total Asset | 36.83 M | |||
| Retained Earnings | (367.94 M) | |||
| Current Asset | 42.39 M | |||
| Current Liabilities | 6.42 M | |||
About Aeterna Zentaris Performance
Assessing Aeterna Zentaris' fundamental ratios provides investors with valuable insights into Aeterna Zentaris' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Aeterna Zentaris is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina. Aeterna Zentaris is traded on NASDAQ Exchange in the United States.Things to note about Aeterna Zentaris performance evaluation
Checking the ongoing alerts about Aeterna Zentaris for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aeterna Zentaris help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aeterna Zentaris is now traded under the symbol CSCI. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Aeterna Zentaris is not yet fully synchronised with the market data | |
| Aeterna Zentaris has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4.58 M. Net Loss for the year was (16.86 M) with profit before overhead, payroll, taxes, and interest of 5.17 M. | |
| Aeterna Zentaris currently holds about 58.16 M in cash with (17.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.98, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Aeterna Zentaris' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aeterna Zentaris' stock is overvalued or undervalued compared to its peers.
- Examining Aeterna Zentaris' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aeterna Zentaris' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aeterna Zentaris' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aeterna Zentaris' stock. These opinions can provide insight into Aeterna Zentaris' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Aeterna Stock
If you are still planning to invest in Aeterna Zentaris check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aeterna Zentaris' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |